Propanc Biopharma, Inc. (PPCB)
0.4635
-0.04
(-7.06%)
USD |
NASDAQ |
Oct 08, 14:45
Propanc Biopharma Price to Book Value : 0.1632 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 0.1756 |
| October 06, 2026 | 0.173 |
| October 05, 2026 | 0.1761 |
| October 02, 2026 | 0.1787 |
| October 01, 2026 | 0.1764 |
| September 30, 2026 | 0.174 |
| September 29, 2026 | 0.1804 |
| September 28, 2026 | 0.1878 |
| September 25, 2026 | 0.222 |
| September 24, 2026 | 0.2119 |
| September 23, 2026 | 0.2211 |
| September 22, 2026 | 0.2292 |
| September 21, 2026 | 0.2217 |
| September 18, 2026 | 0.2148 |
| September 17, 2026 | 0.2219 |
| September 16, 2026 | 0.2236 |
| September 15, 2026 | 0.2888 |
| September 14, 2026 | 0.2993 |
| September 11, 2026 | 0.3243 |
| September 10, 2026 | 0.332 |
| September 09, 2026 | 0.3486 |
| September 08, 2026 | 0.3627 |
| September 04, 2026 | 0.3557 |
| September 03, 2026 | 0.3592 |
| September 02, 2026 | 0.3627 |
| Date | Value |
|---|---|
| September 01, 2026 | 0.3979 |
| August 31, 2026 | 0.4754 |
| August 28, 2026 | 0.4754 |
| August 27, 2026 | 0.7853 |
| August 26, 2026 | 0.3768 |
| August 25, 2026 | 0.3979 |
| August 24, 2026 | 0.4067 |
| August 21, 2026 | 0.3803 |
| August 20, 2026 | 0.3874 |
| August 19, 2026 | 0.4014 |
| August 18, 2026 | 0.4085 |
| August 17, 2026 | 0.405 |
| August 14, 2026 | 0.4296 |
| August 13, 2026 | 0.4296 |
| August 12, 2026 | 0.4261 |
| August 11, 2026 | 0.412 |
| August 10, 2026 | 0.405 |
| August 07, 2026 | 0.4226 |
| August 06, 2026 | 0.4789 |
| August 05, 2026 | 0.4155 |
| August 04, 2026 | 0.3592 |
| August 03, 2026 | 0.3698 |
| July 31, 2026 | 0.3557 |
| July 30, 2026 | 0.3662 |
| July 29, 2026 | 0.3486 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Mesoblast Ltd. | 2.340 |
| Actinogen Medical Ltd. | -- |
Price to Book Value Related Metrics
| Price | 0.4635 |
| Earnings Yield | -5.57K% |
| Market Cap | 1.535M |